Peptide Microarray Discovery for Prostate Cancer Diagnostics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying peptide binders for proteins are expensive, time-consuming, prone to contamination, and lack systematic approaches, limiting their effectiveness in de novo peptide discovery and protein-protein interaction studies, particularly for applications like prostate cancer diagnosis and drug discovery.
Innovation Solution
The development of systems and methods that utilize peptide microarrays with exhaustive peptide maturation and N-terminal and C-terminal extension processes to identify novel peptide binders, specifically for prostate-specific antigen (PSA) and streptavidin, enabling more efficient and accurate identification of peptide binders through comprehensive population screening and optimization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If combinatorial peptide libraries are used for peptide discovery, then peptide binders can be identified, but the process becomes expensive and time-consuming
Solution Approach 1:
The patent performs preliminary actions by pre-synthesizing and immobilizing thousands of unique peptides on a microarray chip before the actual screening process. This allows all peptides to be ready for simultaneous screening against the target protein, eliminating the sequential processing time of traditional library methods while maintaining comprehensive coverage.
Solution Approach 2:
The invention transitions from sequential, solution-phase screening in traditional libraries to parallel, surface-based screening on a microarray. By immobilizing peptides in a two-dimensional array format, the system enables simultaneous screening of multiple peptides against the target, fundamentally changing the dimensionality of the discovery process from linear to parallel.
2Reliability
If combinatorial peptide libraries are used for peptide discovery, then peptide binders can be identified, but the process becomes expensive
Solution Approach 1:
The patent creates a physical copy of the peptide library on a solid microarray surface, where each peptide sequence is synthesized and immobilized at a specific location. This copied array can be screened multiple times without consuming the peptides, allowing repeated experiments and validation at low cost compared to traditional library methods where each screening round consumes library members.
Solution Approach 2:
The microarray chip itself is a disposable, low-cost platform that can be synthesized and used for screening. While individual chips are inexpensive and single-use, they replace the need for expensive, complex library construction and multiple rounds of amplification and screening, overall reducing the cost of the discovery process.
3Reliability
If traditional peptide screening methods are used, then peptide binders can be identified, but contamination occurs
Solution Approach 1:
The patent extracts the peptides from the aqueous solution phase and immobilizes them on a solid microarray support. This extraction from solution to solid phase eliminates the need for liquid handling, washing, and amplification steps that are prone to contamination, while maintaining the ability to screen and identify peptide binders effectively.
4Reliability
If exhaustive peptide maturation and extension processes are performed, then binding affinity is improved, but process complexity increases
Solution Approach 1:
The patent segments the optimization process into distinct stages: initial binder identification from the peptide array, followed by separate maturation steps (amino acid substitutions), and extension steps (adding residues at N- or C-termini). Each stage focuses on a specific aspect of optimization, making the complex overall process more manageable and systematic rather than attempting all optimizations simultaneously.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the identification of high-affinity peptide binders that can be used in diagnostics and therapeutic applications, improving the accuracy of prostate cancer detection and providing novel therapeutic candidates by systematically optimizing peptide sequences for enhanced binding properties.
Implementation Method 1
The microarrays are generally synthesized by using light to direct which oligonucleotides or peptides are synthesized at specific locations on an array
Implementation Method 2
identifying novel peptide binders that bind to a protein target of interest
Data Source
AI summary
The invention comprises systems, methods and arrays for identification and optimization of novel peptide binders to protein targets. Embodiments include steps of peptide binder discovery, core peptide maturation, N-terminal and C-terminal extension and kinetics analysis of the final peptide binder.